Acquisitions (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value Of Total Consideration Transferred And Major Class Of Consideration

The acquisition date fair value of the total consideration transferred and acquisition date fair value of each major class of consideration for the acquisitions completed in the nine months ended September 30, 2015, including post acquisition date adjustments recorded to purchase price allocations, are as follows (in thousands):



	Nine Months Ended September 30, 2015 ⁽¹⁾
Accounts receivable	$	17,560
Other current assets	9,387
Property and equipment	10,679
Goodwill	255,251
Intangible assets	45,600
Other long-term assets	40
Accounts payable	(2,718		)
Other accrued liabilities	(11,600		)
Deferred income taxes	(3,726		)
Other long-term liabilities	(4,957		)
Long-term debt	(3,928		)
Total fair value	311,588
Less: Fair value attributable to noncontrolling interests	72,598
Acquisition date fair value of total consideration transferred	$	238,990


(1)	Represents the preliminary allocation of fair value of acquired assets and liabilities associated with these acquisitions at September 30, 2015.

Revenues And Net Earnings Associated With Acquisitions

evenue and net earnings included in the nine months ended September 30, 2015 and 2014 associated with completed acquisitions are as follows (in thousands):



	Nine Months Ended September 30,
	2015		2014
	Individual Acquisitions		Sheridan		Individual Acquisitions
Net revenue	$	95,026	$	226,545	$	9,925

Net earnings	18,605		19,684		2,293
Less: Net earnings attributable to noncontrolling interests	4,561		164		1,412
Net earnings attributable to AmSurg Corp. common shareholders	$	14,044	$	19,520	$	881

Consolidated Pro Forma Results Of Acquisition

The unaudited consolidated pro forma results for the nine months ended September 30, 2015 and 2014, assuming all 2015 acquisitions had been consummated on January 1, 2014, and all 2014 acquisitions had been consummated on January 1, 2013 are as follows (in thousands, except earnings per share):



	Nine Months Ended September 30,
	2015		2014
Net revenue	$	1,908,259	$	1,770,570
Net earnings	269,405		234,794
Amounts attributable to AmSurg Corp. common shareholders:
Net earnings	105,731		80,423
Net earnings per common share:
Basic	$	2.08	$	1.56
Diluted	$	2.06	$	1.55